NWF Advisory Services Inc. Makes New $1.65 Million Investment in SPDR S&P Biotech ETF $XBI

NWF Advisory Services Inc. acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 10,426 shares of the exchange traded fund’s stock, valued at approximately $1,650,000.

Several other large investors have also modified their holdings of the stock. Avoro Capital Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $256,053,000. Bank of America Corp DE lifted its stake in SPDR S&P Biotech ETF by 13.3% in the first quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after buying an additional 1,700,851 shares during the last quarter. Wells Fargo & Company MN lifted its stake in SPDR S&P Biotech ETF by 75.7% in the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after buying an additional 1,536,122 shares during the last quarter. OMERS ADMINISTRATION Corp boosted its holdings in shares of SPDR S&P Biotech ETF by 42,425.2% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after acquiring an additional 1,187,907 shares during the period. Finally, Morgan Stanley boosted its holdings in shares of SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after acquiring an additional 882,718 shares during the period.

SPDR S&P Biotech ETF Trading Down 0.6%

Shares of XBI opened at $164.38 on Friday. The firm has a market cap of $10.73 billion, a PE ratio of 11.47 and a beta of 0.84. The company’s 50 day simple moving average is $158.01 and its 200-day simple moving average is $140.34. SPDR S&P Biotech ETF has a 12-month low of $92.49 and a 12-month high of $169.89.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.